European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Metabolic and Genetic Regulation of Ageing

Descrizione del progetto

Mantenimento del controllo della qualità cellulare durante l’invecchiamento

Le cellule si affidano a meccanismi precisi per mantenere un insieme stabile e funzionale di proteine, noto come omeostasi proteica. In caso di danni alle proteine provocati dallo stress cellulare, questi sistemi di sorveglianza lavorano insieme per individuare e riparare le strutture danneggiate. Tuttavia, con l’invecchiamento degli organismi, si assiste a un graduale declino della capacità delle cellule di mantenere la stabilità delle proteine, con conseguente deterioramento funzionale. Il progetto MetAGEn, finanziato dal Consiglio europeo della ricerca, studierà il legame fra determinati metaboliti e il controllo della qualità delle proteine. Utilizzando il Caenorhabditis elegans come sistema modello, i ricercatori si baseranno sulle scoperte precedenti per individuare i fattori genetici che influenzano l’invecchiamento e la durata della vita.

Obiettivo

Ageing is a complex physiological process that affects almost all species, including humans. Despite its importance for all of us, the biology of ageing is insufficiently understood. To uncover the molecular underpinnings of ageing, I propose an interdisciplinary research program that will identify and investigate metabolic and genetic regulators of ageing.
Progressive loss of cellular homeostasis causes ageing and an age-associated decline in protein quality control has been implicated in numerous diseases, including neurodegeneration. Seeking for ways to improve protein quality, I have identified a novel longevity pathway in Caenorhabditis elegans. In a forward genetic screen, I found a link between metabolites in the hexosamine pathway and cellular protein quality control. Hexosamine pathway activation extends C. elegans lifespan, suggesting modulation of ageing by endogenous molecules.
In a first step, I will explore the mechanism by which hexosamine metabolites improve protein quality control in mammals, using cultured mammalian cells and a mouse model for neurodegeneration. Preliminary data show that hexosamine pathway metabolites enhance proteolytic capacity in cells and reduce protein aggregation, suggesting conservation. Second, I will investigate molecular mechanisms that activate the hexosamine pathway to promote protein homeostasis and counter ageing. Third, I will perform a direct forward genetic screen for modulators of ageing in C. elegans. For the first time, mutagenesis and next generation sequencing can be paired in forward genetic screens to interrogate the whole genome for lifespan-extending mutations in a truly unbiased manner. This innovative approach has the potential to reveal novel modulators of the ageing process.
Taken together, this work aims to understand molecular mechanisms that maintain cellular homeostasis to slow the ageing process, and to develop a new technology to identify yet unknown genetic modulators of ageing.

Meccanismo di finanziamento

ERC-STG - Starting Grant

Istituzione ospitante

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Contribution nette de l'UE
€ 1 500 000,00
Indirizzo
HOFGARTENSTRASSE 8
80539 Munchen
Germania

Mostra sulla mappa

Regione
Bayern Oberbayern München, Kreisfreie Stadt
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 500 000,00

Beneficiari (1)